Bone Marrow Cell Transplantation to Improve Heart Function in Individuals With End-Stage Heart Failure
Stopped Terminated due to logistical barriers to cell processing and poor enrollment
Conditions
- Heart Failure, Congestive
Interventions
- BIOLOGICAL: Intramyocardial injection of bone marrow mononuclear cells
- BIOLOGICAL: Intramyocardial injection of CD34+ selected bone marrow mononuclear cells
- DEVICE: LVAD alone
Sponsor
Columbia University
Collaborators